NOS1 mutations cause hypogonadotropic hypogonadism with sensory and cognitive deficits that can be reversed in infantile mice

Archive ouverte

Chachlaki, Konstantina | Messina, Andrea | Delli, Virginia | Leysen, Valerie | Maurnyi, Csilla | Huber, Chieko | Ternier, Gaëtan | Skrapits, Katalin | Papadakis, Georgios | Shruti, Sonal | Kapanidou, Maria | Cheng, Xu | Acierno, James | Rademaker, Jesse | Rasika, Sowmyalakshmi | Quinton, Richard | Niedziela, Marek | L’allemand, Dagmar | Pignatelli, Duarte | Dirlewander, Mirjam | Lang-Muritano, Mariarosaria | Kempf, Patrick | Catteau-Jonard, Sophie | Niederländer, Nicolas | Ciofi, Philippe | Tena-Sempere, Manuel | Garthwaite, John | Storme, Laurent | Avan, Paul | Hrabovszky, Erik | Carleton, Alan | Santoni, Federico | Giacobini, Paolo | Pitteloud, Nelly | Prevot, Vincent

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

International audience. The nitric oxide (NO) signaling pathway in hypothalamic neurons plays a key role in the regulation of the secretion of gonadotropin-releasing hormone (GnRH), which is crucial for reproduction. We hypothesized that a disruption of neuronal NO synthase (NOS1) activity underlies some forms of hypogonadotropic hypogonadism. Whole-exome sequencing was performed on a cohort of 341 probands with congenital hypogonadotropic hypogonadism to identify ultrarare variants in NOS1 . The activity of the identified NOS1 mutant proteins was assessed by their ability to promote nitrite and cGMP production in vitro. In addition, physiological and pharmacological characterization was carried out in a Nos1 -deficient mouse model. We identified five heterozygous NOS1 loss-of-function mutations in six probands with congenital hypogonadotropic hypogonadism (2%), who displayed additional phenotypes including anosmia, hearing loss, and intellectual disability. NOS1 was found to be transiently expressed by GnRH neurons in the nose of both humans and mice, and Nos1 deficiency in mice resulted in dose-dependent defects in sexual maturation as well as in olfaction, hearing, and cognition. The pharmacological inhibition of NO production in postnatal mice revealed a critical time window during which Nos1 activity shaped minipuberty and sexual maturation. Inhaled NO treatment at minipuberty rescued both reproductive and behavioral phenotypes in Nos1 -deficient mice. In summary, lack of NOS1 activity led to GnRH deficiency associated with sensory and intellectual comorbidities in humans and mice. NO treatment during minipuberty reversed deficits in sexual maturation, olfaction, and cognition in Nos1 mutant mice, suggesting a potential therapy for humans with NO deficiency.

Consulter en ligne

Suggestions

Du même auteur

GnRH replacement rescues cognition in Down syndrome

Archive ouverte | Manfredi-Lozano, Maria | CCSD

International audience. At the present time, no viable treatment exists for cognitive and olfactory deficits in Down syndrome (DS). We show in a DS model (Ts65Dn mice) that these progressive nonreproductive neurolog...

KLB , encoding β‐Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism

Archive ouverte | Xu, Cheng | CCSD

International audience. Congenital hypogonadotropic hypogonadism (CHH) is a rare genetic form of isolated gonadotropin-releasing hormone (GnRH) deficiency caused by mutations in > 30 genes. Fibroblast growth factor ...

A microRNA switch regulates the rise in hypothalamic GnRH production before puberty

Archive ouverte | Messina, Andrea | CCSD

International audience. A sparse population of a few hundred primarily hypothalamic neurons forms the hub of a complex neuroglial network that controls reproduction in mammals by secreting the 'master molecule' gona...

Chargement des enrichissements...